🇬🇧 Experts call for urgent action to develop antibiotics for newborns
07 Dec, 2022
Padua (Italy), 7 December 2022 – Leading public health experts from around the globe are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly…
Read More
🇮🇹 Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni
30 Jun, 2022
Padova, 30 giugno 2022 Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni. Lo dimostra un ampio studio appena pubblicato…
Read More
🇬🇧 Study reveals moderate effectiveness of Pfizer Covid-19 vaccine against Omicron in children aged 5-11
30 Jun, 2022
Padua, 30 June 2022 – A large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine. The study…
Read More
🇬🇧 GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections
26 Apr, 2022
Geneva, 26 April 2022 – A large study focusing on newborn babies with clinically diagnosed sepsis has revealed the impact of antibiotic resistance on neonatal sepsis, a major cause of…
Read More
🇮🇹 Uno studio di GARDP rivela che i neonati muoiono sempre più frequentemente per sepsi neonatale causata da infezioni batteriche resistenti ai farmaci
26 Apr, 2022
Ginevra, 26 Aprile 2022 – Un importante studio sui neonati ha rivelato l’impatto della resistenza agli antibiotici sulla sepsi neonatale, una delle principali cause di morte tra i neonati. Al…
Read More
🇬🇧 European RBDCOV project to study HIPRA’s COVID-19 vaccine in children adolescents and immunocompromised patients
15 Feb, 2022
Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein. …
Read More
🇬🇧 Easy-to-take medicine better at suppressing HIV in children
30 Dec, 2021
UCL press release A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global…
Read More
🇬🇧 NeoVanc: New study finds no clear benefit from a shorter optimised vancomycin treatment in babies with Gram positive late onset sepsis
27 Nov, 2021
The results of the study show that there is no clear advantage for adopting a shorter 5-day course, with a loading dose, over the standard 10-day course in infants under…
Read More
🇬🇧 VERDI project launches
15 Nov, 2021
Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants The University of Padua and Penta Foundation are leaders of VERDI, a new European research…
Read More
🇬🇧 New data on the duration of immune protection against SARS-CoV- 2 in children
02 Jul, 2021
A study published in the Pediatrics journal shows that children with mild forms of COVID-19 develop a greater and longer lasting antibody response than that of adults. The study involved 57…
Read More
🇮🇹 Nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini
28 Jun, 2021
Università degli Studi di Padova, Istituto Zooprofilattico Sperimentale delle Venezie e Penta presentano nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini Uno studio pubblicato in questi giorni…
Read More
🇮🇹 NeoIPC: strategie di prevenzione e di controllo delle infezioni neonatali
15 Jun, 2021
Parte da Padova il progetto europeo NeoIPC, che mira a ridurre le infezioni e la trasmissione di batteri resistenti nelle unità di terapia intensiva neonatale. Padova, 15 giugno 2021 –…
Read More
🇬🇧 NeoIPC: a new project to improve prevention and control of infections in newborns
19 May, 2021
NeoIPC, a project seeking to reduce the transmission of resistant bacteria in neonatal intensive care units, has just launched.
Read More
🇮🇹 CORONA: bambini e COVID-19
21 Apr, 2021
Un progetto a guida italiana sostenuto da UniCredit Foundation Padova, 21 Aprile 2021 – Parte il progetto CORONA: bambini e COVID-19, sostenuto da UniCredit Foundation e condotto dalla Fondazione Penta di…
Read More
🇬🇧 CORONA: children and COVID-19
21 Apr, 2021
An Italian-led project supported by the UniCredit Foundation to study the impact of the coronavirus on children.
Read More
🇬🇧 New European-African collaboration to develop UNIVERSAL treatments for children living with HIV
03 Feb, 2021
Today marks the official launch of UNIVERSAL, the newly funded European-African clinical research partnership that aims to develop two antiretroviral formulations for children living with HIV and to speed up…
Read More
🇬🇧 PREPARE activated to Mode 2 in response to novel Coronavirus cases in Europe
06 Feb, 2020
On 30th January 2020, the Director General of the World Health Organisation (WHO) declared the outbreak of 2019-nCoV a public health emergency of international concern. In his statement, Dr Tedros…
Read More
🇬🇧 GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR
01 Apr, 2019
Geneva / Padova, Monday 4 March 2019 – The Global Antibiotic Research & Development Partnership (GARDP) and Penta, the paediatric infectious diseases research network, have joined forces to tackle drug-resistant…
Read More
🇬🇧 University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics
01 Apr, 2019
Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative…
Read More